Bola

“We’re extremely excited to offer Bola AI to our customers,” said Brad Joseph, VP of product management at Patterson Dental. “Our Fuse customers consistently tell us they love the intuitive nature of using Fuse, and our Eaglesoft customers appreciate how user-friendly Eaglesoft is. Integrating Bola AI’s voice technology provides our customers with another intuitive, user-friendly tool to streamline their workflow, improve efficiency, and save time and resources for their hygienists, office staff, and patients.”

Bola AI’s Voice Perio is the first clinical voice assistant for the dental market to utilize this new age of technology while providing unprecedented ease of use and high speech accuracy. It achieves this by filtering out background noise and non-clinical speech, and it supports both flexible phrasing and a range of clinician accents.

Bola AI’s Voice Perio system enables dental staff to seamlessly record periodontal data directly into their practice management software in real time. It is now integrated directly into the Fuse cloud-based practice management software and Eaglesoft practice management software.

“We’re looking forward to working with the team at Patterson to provide an improved dental experience for professionals and patients alike,” said Rushi Ganmukhi, CEO and founder of Bola AI. “Bola’s integration with Fuse and Eaglesoft is another positive step toward our shared goal of utilizing cutting-edge technology to revolutionize the modern dental environment.”

To learn more about the Fuse and Bola AI authorized integration, visit https://bola.ai/practice-management-partners/fuse/. To learn more about the Eaglesoft and Bola AI authorized integration, visit https://bola.ai/practice-management-partners/eaglesoft/.

About Patterson Dental

Patterson Dental, a subsidiary of Patterson Companies Inc. (Nasdaq: PDCO), connects dental customers in North America to the latest products, technologies, services, and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network, and supply chain are equaled only by our dedicated, knowledgeable people who deliver unrivaled expertise and unmatched customer service and support. Learn more: www.pattersondental.com.

About Bola AI

Bola AI is the leader in Voice-AI software for dental practices. By harnessing the power of advanced technologies, this platform provides efficient, fully integrated, and highly accurate speech solutions for periodontal charting, clinical notes, and more. With Bola AI, practices can create a smarter patient experience while improving operational efficiency and driving revenue. Bola is headquartered in Orange County, CA. For more information, visit www.bola.ai.

“NovoHealth Dental has demonstrated that its pre-emptive claim quality assurance checks, reliable fraud detection, and accurate clinical assessments can deliver significant ROI,” said Jim Hinkle. “With the platform’s ability to securely and successfully analyze millions of claims flowing through high-volume, real-time environments, NovoHealth Dental is the right AI for U.S. dental insurers who want and need the best-in-class, enterprise-scale dental AI solution.”

Jim has an outstanding track record in helping customers succeed with performance improvement, digital transformation, and healthcare analytics technologies. He joins NovoDynamics after serving for half a decade as Senior Vice President of Sales for Health Data Management Solutions, a CVS Health/Aetna Health Analytics Company, and several years as VP of Business Development for Philips Consulting. Over the course of his career in the healthcare industry, Jim has held leadership positions with responsibilities ranging from Strategic Operations to Strategic Partnerships. Jim currently serves as a Board Member for the Integrated Benefits Institute, a non-profit that provides unbiased research and insights to help employers and providers make health decisions that positively impact the “3Ps”: people, productivity, and performance.

According to David Rock, Chairman and CEO of NovoDynamics, “NovoHealth Dental has been proven at major U.S. dental insurance companies, so we are well positioned for continued growth. We look forward to having Jim apply his expertise to expand our customer and partner relationships.”

Jim earned his Master of Health Administration (MHA) from the Medical University of South Carolina, specializing in Operations and Financial Health System Management, and his BA in Political Science from the College of Charleston, focusing on International Relations, Middle Eastern Politics, International Conflict, and War and Diplomacy.

About NovoDynamics, Inc.

NovoDynamics provides artificial intelligence (AI) solutions that address critical healthcare challenges, save payers and providers time and money, and help improve the quality of care for patients. The NovoDynamics® NovoHealth® Dental platform analyzes dental insurance claims in real time, delivers accurate clinical assessments, helps deter fraud, waste, and abuse, and supports more consistent plan payments. NovoDynamics, an In-Q-Tel portfolio company, has been applying its proven AI expertise and advanced image processing technology to solve complex problems for governments, commercial enterprises, and academic institutions since 2001. For more information, follow NovoDynamics on LinkedIn or visit NovoDynamics.com.

FEATURED IMAGE CREDIT: Miguel Á. Padriñán from Pexels.com.

“HITRUST Certification is just one of the many ways we are leading our industry,” said NovoDynamics CEO David Rock. “NovoDynamics’ best-in-class dental AI solutions streamline dental insurance claim reviews to benefit payers, providers, and patients alike. NovoHealth Dental’s unparalleled features include pre-emptive claim quality assurance checks, reliable fraud detection, and accurate clinical assessments. Plus, NovoHealth Dental has been proven to successfully analyze claims in a high-volume, real-time environment.”

“HITRUST r2 Certification demonstrates NovoDynamics is taking the most proactive approach to cybersecurity, data protection, and risk management,” said Bimal Sheth, Executive Vice President, Standards Development & Assurance Operations at HITRUST. “The HITRUST Assurance Program is rigorous and reliable because of the comprehensiveness of control requirements, depth of review, and consistency of oversight.”

About HITRUST r2 Certification

HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the NovoDynamics NovoHealth Dental platform has met key regulations and industry-defined requirements and is appropriately managing risk. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls. During 2022 and 2023, more than 99.4% of HITRUST Certified environments proved resilient in fending off potential security breaches.

About NovoDynamics

NovoDynamics provides artificial intelligence (AI) solutions that address critical healthcare challenges, save payers and providers time and money, and help improve quality of care for patients. The company’s NovoHealth Dental platform analyzes dental insurance claims in real time; delivers accurate clinical assessments; helps deter fraud, waste, and abuse; and supports more consistent plan payments. NovoDynamics, an In-Q-Tel portfolio company, has been applying its proven AI expertise and advanced image processing technology to solve complex problems for governments, commercial enterprises, and academic institutions since 2001.

For more information, follow NovoDynamics on LinkedIn or visit NovoDynamics.com.

FEATURED IMAGE CREDIT: Gerd Altmann from Pixabay.

DecisionOne Dental blends the independence and patient-centered focus of private practice with the efficiency and support of a DSO. Clinicians who join the DecisionOne Dental team value their culture of support and encouragement and their vast and thoughtful network of established business systems. DecisionOne Dental protects and supports its clinical teams by constantly evaluating operational and clinical technology. It ensures that every investment is considered part of a comprehensive toolbox and can be leveraged to deliver the best possible care.

Dr. Alan J. Acierno, co-founder of DecisionOne Dental Partners and president of clinical operations at Smile Brands, said, “While dental AI is incredibly exciting and promising, it is also a young market. As such, we were incredibly rigorous about our selection process. We felt VideaHealth was a great partner for our doctors, teams, and patients.”

VideaAI, VideaHealth’s dental AI platform, has quickly become the most commonly used AI technology across leading DSOs, with tens of thousands of dental clinicians using it daily, supporting the diagnosis of millions of patients yearly. VideaAI has been widely lauded for its ease of use, enabling clinicians to streamline administrative tasks and focus more on delivering optimal patient care with access to previously unattainable insights.

VideaHealth’s dental AI platform is currently leveraged in leading DSO and independent practices in the US. Its early leadership position quickly accelerated in 2024, as it was the first dental AI company to offer insights for virtually every disease state in dentistry, as well as enabling diagnosis of pediatric conditions.

Florian Hillen, CEO of VideaHealth, said, “I admire the approach DecisionOne Dental Partners has taken. Their patient-care-focused model is among the very best in the industry, and I know from speaking with their team that they take their mission as seriously as we do. We’re so pleased they have recognized the value our AI brings, and we expect to see consistent and outstanding results based on trends within the entire market.”

VideaHealth’s investment in the success of every rollout, through advanced onboarding and training support and continuous customer success alignment, has historically led to over 90% adoption among clinicians and hygienists. Moreover, the company’s current technology leadership and anticipated roadmap make it clear that VideaHealth will deliver for customers today and for many years to come.

About VideaHealth

VideaHealth is the leading dental AI company, offering dental providers the most comprehensive suite of dental AI technology that addresses virtually every dental disease state. Practices of all sizes are using VideaHealth’s AI platform to drive better clinical outcomes, ranging from the nation’s largest DSO, Heartland Dental, to forward-facing independent practices.

Through a partnership with Henry Schein One, one of the country’s most respected technology companies, VideaHealth is also bringing the co-branded Dentrix Detect AI and Dentrix Ascend AI powered by VideaHealth to the tens of thousands of offices using the company’s practice management software.

Headquartered in Boston, VideaHealth is backed by leading venture capital firms Spark Capital, Zetta Venture Partners, and Pillar VC.

For more information, visit https://www.videa.ai.

With this investment, Pearl will continue to advance innovation in technologies that enhance the health of dental patients around the world by expanding its line of dental AI products, broadening its regulatory and patent portfolio, and increasing global access to the transformative benefits of AI in dentistry. At present, Pearl’s machine learning and computer vision tools solve a core challenge in dentistry: inconsistency in diagnostic accuracy, which directly impacts the quality of patient care. The company’s AI serves as a real-time aid to help dentists read patient x-rays, deliver consistent, objective, and accurate diagnoses, and clearly communicate findings to patients with precision, clarity, and confidence.

Since receiving the first-ever FDA clearance for AI software to help dental professionals detect multiple different pathologies and other conditions in x-rays, Pearl’s clinical AI has gained regulatory authorizations for chairside use in over 120 countries and recognition among TIME’s Best Inventions. The company plans to use the funding announced today both to accelerate ongoing development of computer vision capabilities—including detection and tracking of disease in 3D and other imaging modalities—and introduce new AI tools to improve patient treatment planning, insurance claim approvals, and dental education.

“In the field of healthcare, dentistry has become an AI standard-bearer, demonstrating the technology’s enormous utility and benefit in day-to-day patient care––and Pearl has led the AI charge in dentistry,” said Ophir Tanz, founder and CEO of Pearl. “This historic funding round underscores the impact of Pearl’s capabilities and supports our belief that high-quality, AI-powered dental care should be accessible to everyone. With this investment, Pearl will continue to push the envelope, providing pioneering machine learning to improve oral health outcomes and strengthen trust between patients and dental professionals.”

This investment follows a period of significant growth for Pearl. The company grew its revenue by 458% in 2023 and remains the only dental AI company with a global market presence. Pearl’s technology is used in dental practices across six continents and is commercially available to over 500,000 dental practices and millions of dental professionals worldwide. The company has also integrated its AI into dozens of popular imaging and practice management systems and is the preferred radiologic AI provider for leading dental technology distributors.

“We have spent the past year evaluating this market and it is clear that Pearl stands above peers at the forefront of dental innovation,” said Vinny Pujji, Managing Partner at Left Lane Capital. “Pearl’s pioneering dental AI improves diagnostic accuracy and efficiency while transforming the provider-patient relationship. We’re confident in Pearl’s ability to continue setting new standards of care and are thrilled to support their next phase of growth.”

Pearl’s AI technology offers a seamless and less invasive approach to dental diagnostics. By accurately detecting disease and displaying clinical findings that are easy for patients to understand, the company’s FDA-cleared software enhances the efficiency, consistency, and precision of radiologic exams, while also facilitating patient education and engagement in their dental health. Leveraging its new funding, Pearl will enable dental professionals to continually raise the standard of care with more transparent, accurate, and objective diagnoses, more effective individualized care, and deeper patient trust in dentistry.

For more information on how Pearl’s suite of solutions can enhance your dental practice, visit hellopearl.com.

About Pearl

Pearl is an AI-driven company committed to enhancing patient care in dentistry. Founded in 2019 by a team with decades of experience developing successful, enterprise-grade computer vision solutions, Pearl introduced the first-ever FDA-cleared AI capable of reading and instantly identifying diseases in dental x-rays. With regulatory clearance in 120 countries, Pearl’s AI assists dentists in making precise clinical decisions and effectively communicating with patients, thereby transforming the dental care experience worldwide. As dentistry’s global AI leader, Pearl is committed to the ongoing innovation of robust, accessible AI tools that improve patient health outcomes and build greater trust in dental medicine. To request a demo, please visit hellopearl.com/getdemo.

About Left Lane Capital

Founded in 2019, Left Lane Capital is a New York and London-based global venture capital and growth equity firm investing in internet and technology companies with a consumer orientation. Left Lane’s mission is to partner with extraordinary entrepreneurs who create category-defining companies across growth sectors of the economy, including software, healthcare, e-commerce, consumer, fintech, medtech, and other industries. Select investments include Bilt Rewards, Polycam, Kings League, M1 Finance, Wayflyer, Masterworks, Blank Street, Talkiatry, LemFi, and more. For more information, please visit www.leftlane.com.

Dental Care Alliance and Overjet Launch Historic Rollout of AI

“Transforming dental care through AI isn’t just about innovation or technology,” said Jason Heffelfinger, CEO of Dental Care Alliance. “It’s about empowering our supported providers, advancing precision, personalizing patient experiences, and pioneering a new era of oral health. We are proud to partner with Overjet to be the first DSO to implement this game-changing platform across our family of more than 400 affiliated practices.”

Overjet is the AI platform for dentistry. Its FDA-cleared technology is trained on millions of X-rays and continuously tested by a team of leading dentists, enabling it to detect, outline, and quantify oral diseases with millimeter-level precision. In addition to analyzing X-rays, Overjet is also an essential tool for educating patients, since it highlights cavities, calculus, and other pathologies with colorful overlays that patients can understand. The result is greater trust in the dentist, which leads to higher case acceptance.

DCA’s leadership recognizes that its success with AI will depend on its people, who are ultimately responsible for understanding and implementing the new technology. That was the motivation for DCA’s unique and comprehensive rollout plan, carefully designed to maximize Overjet’s impact across all of its providers. Through a combination of in-depth training sessions and study clubs led by Overjet’s expert clinical team, deep integrations with providers’ existing systems, and high-profile promotional campaigns, DCA is setting the example for how to implement dental AI at scale.

This organization-wide expansion builds on DCA’s initial partnership with Overjet that began in May 2022, and which has produced overwhelmingly positive reactions from both its providers and patients. Beyond the dental chair, the platform will help DCA’s providers grow their practices — from streamlining the morning huddle to identifying opportunities for care.

“The most successful DSOs of tomorrow will be those that embrace AI today,” said Wardah Inam, CEO of Overjet. “From the very beginning of our partnership, DCA’s leaders wanted to do more than just keep pace with the latest technology. They wanted to push dentistry forward. With this milestone deployment of AI, Dental Care Alliance will set the new standard for what patients expect at the dentist.”

About Dental Care Alliance

Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports over 400 allied practices and supports over 900 dentists across 24 states. DCA’s allied practices represent all dental specialties and treat patients under more than 150 brand names. Learn more at dentalcarealliance.com.

About Overjet

Overjet is the world-leader in dental AI. Founded by experts from MIT and Harvard University, Overjet builds artificial intelligence that helps dental organizations give patients the highest quality of care. Our FDA-cleared technology is the first objective standard for making oral health decisions — so that dentists can detect pathologies with precision and educate patients with confidence. To learn more, visit Overjet.com.

Pearl’s real-time pathology detection AI software, Second Opinion, assists dentists in their radiologic evaluation and case presentation of dental conditions commonly found in dental x-rays, including caries, bone loss, calculus, and more. The technology, which received its Medical Device Establishment License (MDEL) from Health Canada in 2021, enables dentists to read patient x-rays more accurately and efficiently, enhancing their clinical performance and patient communication.

“For decades, Patterson Dental Canada has been committed to providing tailored solutions that meet the dental industry’s rapidly evolving needs,” said Dan Begin, Region President of Patterson Dental Canada. “Pearl’s innovative AI-backed technology has set a new standard of care within dentistry. By adding Pearl’s AI to our leading dental software offerings, we are furthering our commitment to enabling the most advanced dental care across thousands of Canadian dental practices.”

This announcement marks an expansion of Pearl’s commercial ties with Patterson Companies, Inc. In November 2023, Pearl and Patterson Dental Supply, Inc. established an integration with Pearl’s AI feature set natively within Patterson’s Eaglesoft, Fuse, and Dolphin practice management software platforms. By expanding Second Opinion® access in Canada, Pearl’s connection with Patterson Dental Canada makes the benefits of advanced clinical AI available to every Patterson Dental customer across North America.

“Patterson Dental Canada is one of the most trusted names in dental technology,” said Ophir Tanz, founder and CEO of Pearl. “We are proud to work together in advancing our mission to elevate the global standard of care in dentistry.”

About Pearl

Pearl is an AI-driven company committed to enhancing patient care in dentistry. Founded in 2019 by a team with decades of experience developing successful, enterprise-grade computer vision solutions, Pearl introduced the first-ever FDA-cleared AI capable of reading and instantly identifying diseases in dental x-rays. With regulatory clearance in 120 countries, Pearl’s AI assists dentists in making precise clinical decisions and effectively communicating with patients, thereby transforming the dental care experience worldwide.

As dentistry’s global AI leader, Pearl is committed to the ongoing innovation of robust, accessible AI tools that improve patient health outcomes and build greater trust in dental medicine. To request a demo, please visit hellopearl.com/getdemo.

About Patterson Companies Inc.

Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain are equaled only by our dedicated, knowledgeable people who deliver unrivaled expertise and unmatched customer service and support.

Learn more at www.pattersoncompanies.com.

The intraoperative use of uAI MERITS

Overcoming Challenges in Oral and Maxillofacial Reconstructive Surgery 

This surgery helped a patient who had lost part of her mandible due to cancer by successfully reconstructing the mandible and restoring normal aesthetics and functions. The surgery involved the transplantation of a free fibular flap from the patient’s lower leg, which encompassed bone, and soft tissue, to reconstruct the missing mandible and oral mucosa. At the same time, dental implants were placed in the newly transplanted bone, restoring the patient’s masticatory functions, anatomical structures, and facial aesthetics.

Maxillofacial reconstruction surgeries have been constrained by the complexity of anatomical structures, the high demands for aesthetics and functionality, and the necessity for surgical precision. In this case, the accurate identification and localization of perforator vessels within the soft tissue were pivotal to the success of mandibular reconstruction using a free fibula flap.

In traditional approaches, it is imperative for surgeons to possess an exceptionally high-level of expertise and extensive surgical experience to minimize errors when localizing perforator vessels. Historically, physicians have relied on auxiliary tools such as ultrasound to estimate the location of these perforator vessels, a method that often lacks precision and fails to achieve optimal surgical outcomes. Moreover, the surgical process demands a significant expenditure of time and effort from the surgeons, who must manually compare and delineate between conventional cross-sectional CT images and the surgical site. This process poses considerable challenges to the efficiency and accuracy of the surgery.

AI-Assisted Oral and Maxillofacial Reconstructive Surgery Achieves Outstand Results

For the first time, Professor Su’s team successfully completed an oral and maxillofacial reconstructive surgery with the assistance of a large multimodal model for medicine. The innovation of this technology lies in its ability to address the clinical challenge of surgeons relying on empirical knowledge and best estimates to locate perforating vessels during free flap harvesting surgery. This solution is achieved through a robust, large-scale transformer model trained on a diverse array of medical images for precise segmentation preoperatively, and a large multimodal model for 3D image and video registration, prospective projection, and dynamic visual tracking intraoperatively. This integrated approach significantly improves surgical efficiency and accuracy.

Empowered by AI, the mandibular reconstruction surgery utilized the UII Discover – Runoff CTA system, an advanced intelligent system for evaluating the arteries of the lower extremity. This system facilitated rapid and automatic reconstruction of a comprehensive 3D model of the lower limb’s arteries, bones, and skin, offering a multimodal, 360° rotational view. It intelligently identified and outlined the perforator vessels in the leg, and displayed them in various colors, which streamlined the preoperative planning process and enhanced surgical efficiency.

During the surgery, the uAI MERITS system, which integrates advanced AI technologies such as large multimodal models and digital twins, played a pivotal role in enhancing precision and efficiency. It provided real-time projection of anatomy that intelligently and dynamically aligned the 3D reconstruction from the CTA system with the patient’s surgical site, seamlessly adapting to patient movement without compromising the accuracy of the procedure. This goggle-free approach allowed for the rapid and precise delineation of the surgical field, significantly improving the precision and success rate of the surgery.

The success of this oral and maxillofacial reconstructive surgery is a testament to the integration of cutting-edge technologies, such as AI and large multimodal models, with real-world medical use cases. It also marks the world’s first oral and maxillofacial reconstructive surgery driven by a large multimodal model for medicine.

Currently, the team has successfully completed three oral and maxillofacial reconstructive surgeries using the uAI MERITS platform. Notably, distinct from the first two free fibula flap surgeries, the third surgery marked a milestone by introducing another groundbreaking technique of harvesting the anterolateral thigh flap for the first time.

At the International Society for Oral and Maxillofacial Rehabilitation Conference held in Hong Kong in June, Professor Su shared a successful case of using uAI MERITS for oral and maxillofacial reconstructive surgery, which garnered widespread attention from the attending experts and clinicians. Additionally, James J. Xia, M.D., Ph.D., Chief Medical Officer at United Imaging Intelligence, shared the latest advances of AI technology in the field of medicine. He expressed that the company will continue to collaborate with medical professionals to discover more clinical use cases and develop more clinical applications leveraging large model technology, thereby expanding possibilities for physicians and patients worldwide.

Disclaimer: Products and features mentioned herein may not be commercially available in all countries. Their future availability cannot be guaranteed.

Riccobene + VideaHealth

Lorri Detrick, chief operations officer of Riccobene Associates, said, “We have long invested in equipping our clinicians with the most advanced technology and diagnostic equipment so they can deliver the best possible patient care. VideaHealth made the adoption of dental AI easy for our teams; it is easy to use, accurate, and has a very positive impact on our practices. This expansion of our relationship with VideaHealth is a testament to the power of their technology and the quality of their team.”

VideaHealth’s dental AI platform is currently leveraged in the leading DSO and independent practices in the US. Its early leadership position has quickly accelerated in 2024, as it was the first dental AI company to offer insights for virtually every disease state in dentistry, as well as enabling diagnosis of pediatric conditions.

VideaAI has been widely lauded for its ease of use, enabling clinicians to streamline administrative tasks and focus more on delivering optimal patient care with access to previously unattainable insights. It does this while preserving clinical autonomy in diagnostic and treatment decisions.

Chief dental officer Miguel Gonzalez said, “Quality patient care is everything to us. VideaAI can be leveraged for so many significant clinical findings; it gives our teams additional diagnostic validation and deeper insights. The AI is intuitive and easy to use, integrating easily into our clinical workflow. It’s no surprise that our dentists and hygienists quickly embraced VideaAI. However, they’re not the only ones who have taken a liking to the product. Patients are also quickly adopting it, leading to significant improvements in patient education and treatment decision-making. VideaHealth has everything we need and more.”

About VideaHealth

VideaHealth is the leading dental AI company, offering dental providers the most comprehensive suite of dental AI technology that addresses virtually every dental disease state. Practices of all sizes are using VideaHealth’s AI platform to drive better clinical outcomes, ranging from the nation’s largest DSO, Heartland Dental, to forward-facing independent practices.

Through a partnership with Henry Schein One, one of the country’s most respected technology companies, VideaHealth is also bringing the co-branded Dentrix Detect AI and Dentrix Ascend AI powered by VideaHealth to the tens of thousands of offices using the company’s practice management software.

Headquartered in Boston, VideaHealth is backed by leading venture capital firms Spark Capital, Zetta Venture Partners, and Pillar VC.

For more information, visit https://www.videa.ai.

As the dental industry continues to evolve, this new partnership reflects Archy’s continued commitment to providing its users with the most advanced tools and technologies to streamline operations, optimize workflows, and improve patient outcomes. Archy’s all-in-one practice management software is designed to help dental practices reduce costs by eliminating the need for multiple add-on software packages, offering all services, from payroll to charting to patient engagement tools, in one streamlined solution.

“At Archy, we empower dental practices with cutting-edge technology, providing a true one-stop shop for everything they need to run their practice efficiently,” said Archy CEO, Jon Rat. “Partnering with Pearl to integrate their advanced AI capabilities into our all-in-one practice management software was a natural step, as we believe AI is the future of dentistry.”

Pearl’s Second Opinion® enables increased patient understanding and improved visualization of dental conditions, leading to more effective patient communication and higher treatment acceptance rates. Through advanced computer vision technology, Second Opinion helps dentists identify and highlight key pathological and non-pathological findings in patients 12 and older, including dental caries, bone loss, root abscesses, calculus, faulty restorations, impactions, crowns, fillings, and more.

“Archy is changing practice management by blending its unique technical expertise with real-world dental experience, equipping dental practices across the U.S. with a centralized solution that checks all the boxes of running an effective practice,” said Pearl founder and CEO, Ophir Tanz. “We look forward to working with Archy on our shared mission to empower dental providers with the AI-powered insights they need to deliver better oral health outcomes to patients.”

Second Opinion® will now be included in Archy’s Platinum plans and is also available as an upgrade to the Gold plan. Existing Archy customers interested in adding Pearl to their accounts can reach out to support@archy.com.

Dental professionals who are unfamiliar with Archy and interested in learning more about how the software works with Pearl can also book a demo at archy.com.

About Pearl

Pearl is an AI-driven company committed to enhancing patient care in dentistry. Founded in 2019 by a team with decades of experience developing successful, enterprise-grade computer vision solutions, Pearl introduced the first-ever FDA-cleared AI capable of reading and instantly identifying diseases in dental x-rays. With regulatory clearance in 120 countries, Pearl’s AI assists dentists in making precise clinical decisions and effectively communicating with patients, thereby transforming the dental care experience worldwide. As dentistry’s global AI leader, Pearl is committed to the ongoing innovation of robust, accessible AI tools that improve patient health outcomes and build greater trust in dental medicine.

To request a demo, please visit hellopearl.com/getdemo.

About Archy

Archy is the fastest-growing practice management software, designed to help dental practices save both time and money. Founded with the mission to modernize dental practice management, Archy offers an all-in-one suite of cloud-based tools, including scheduling, online forms, insurance claims processing, imaging, two-way texting, email marketing, reporting, and much more. By eliminating the need for physical servers and third-party software for functions like imaging and patient communications, Archy helps dental practices streamline operations and reduce costs. Trusted by dental professionals nationwide, Archy is committed to continuous innovation, providing user-friendly and scalable solutions that enhance patient care and practice efficiency. To request a demo, please visit archy.com/demo.